Molecular Analysis of Thoracic Malignancies
Trial ID or NCT#
Status
Purpose
A research study to learn about the biologic features of cancer development, growth, and spread. We are studying components of blood, tumor tissue, normal tissue, and other fluids, such as urine, cerebrospinal fluid, abdominal or chest fluid in patients with cancer. Our analyses of blood, tissue, and/or fluids may lead to improved diagnosis and treatment of cancer by the identification of markers that predict clinical outcome, markers that predict response to specific therapies, and the identification of targets for new therapies.
Official Title
Molecular Analysis of Thoracic Malignancies
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Jordan Preiss
650-723-1002
View on ClinicalTrials.gov